Page last updated: 2024-12-07
cloturin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Cloturin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 128676 |
SCHEMBL ID | 9621609 |
MeSH ID | M0161183 |
Synonyms (21)
Synonym |
---|
cloturin |
vufb-15686 |
n-(2-chloroethyl)thiocarbamic acid 6-purinyl ester |
6-(n-(2-chloroethyl)carbamoyl)thiopurine |
carbamothioic acid, (2-chloroethyl)-, s-1h-purin-6-yl ester |
s-1h-purin-6-yl (2-chloroethyl)carbamothioate |
ccris 7602 |
6-(n-(2-chloroethyl)carbamoyl)thio purine |
cloturine |
s-(7h-purin-6-yl) n-(2-chloroethyl)carbamothioate |
AKOS024344543 |
eqt0968qnx , |
unii-eqt0968qnx |
104789-46-0 |
6-[n-(2-chloroethyl)carbamoyl]thiopurine |
OQBORDVFGPUGDV-UHFFFAOYSA-N |
SCHEMBL9621609 |
DTXSID80146738 |
s-(1h-purin-6-yl) (2-chloroethyl)carbamothioate |
Q27277312 |
STARBLD0004634 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.41
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.41) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |